10:53 GMT26 February 2021
Listen Live
    Get short URL

    Sputnik V became the first-ever registered vaccine against coronavirus in the world in August 2020, and showed over 90 percent efficiency during trials.

    The Russian Direct Investment Fund (RDIF), which is behind the production and distribution of the Russian-made vaccine Sputnik V, announced that 100 million doses of the medication may be provided for the EU during the next quarter of the year.

    Earlier this month, the Russian vaccine was authorised by Hungary, which became the first EU member state to approve Sputnik V.

    European countries have recently faced some issues with their mass vaccination plans since the UK-Swedish pharma giant AstraZeneca declared it would cut Q1 2021 deliveries of its vaccine to the bloc by up to 60 percent, while guaranteeing deliveries to the United Kingdom.

    In response, European Council President Charles Michel warned that Brussels may take "urgent measures to ensure effective vaccine production and supply", hinting at the possible suspension of Pfizer vaccine exports from the EU.

    Vaccines, Vaccine, Russian Direct Investment Fund (RDIF), Russia, Sputnik V, coronavirus, COVID-19
    Community standardsDiscussion